Validating RBM Technology Under GCP and Data Integrity Requirements
Validating RBM Technology Under GCP and Data Integrity Requirements The landscape of conducting clinical trials is continuously evolving, particularly with the advent of technology that enhances efficiency and data integrity. Risk-Based Monitoring (RBM) has become a focal point for numerous organizations, aiming to optimize clinical trial processes while ensuring compliance with Good Clinical Practice (GCP)…
Read More “Validating RBM Technology Under GCP and Data Integrity Requirements” »